MRNA
NASDAQ · Biotechnology
Moderna Inc
$241.46
-16.92 (-6.55%)
Performance
1D
—
1W
+8.90%
1M
+22.89%
3M
+303.71%
6M
+356.62%
1Y
+892.44%
YTD
+682.44%
Open$258.01
Previous Close$258.38
Day High$261.00
Day Low$237.65
52W High$254.48
52W Low$22.28
Volume—
Avg Volume20.22M
Market Cap87.83B
P/E Ratio—
EPS$-7.98
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$187.78
Above
SMA 200
$89.50
Above
RSI (14)
57
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
31 analysts
Price Target
-38.1% upside
Current
$241.46
$241.46
Target
$149.45
$149.45
$89.97
$149.45 avg
$212.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.98B | 4.25B | 2.23B |
| Net Income | -2,873,788,769 | -5,555,004,063 | -285,156,561 |
| Profit Margin | -145.2% | -137.9% | -12.8% |
| EBITDA | -2,911,461,567 | -5,940,482,149 | -355,384,473 |
| Free Cash Flow | — | — | -237,052,091 |
| Rev Growth | -53.4% | -53.4% | +3.0% |
| Debt/Equity | 0.07 | 0.07 | 0.52 |
Recent Insider Activity
All Insiders →| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 16 | Hoge Stephen | Exercise | 1,638,482 | $12.21 | $20.01M |
| Oct 16 | Hoge Stephen | Sale | 1,599,708 | $213.47 | $341.49M |
| Oct 16 | Hoge Stephen | Sale | 1,599,258 | $214.15 | $342.48M |
| Oct 16 | Hoge Stephen | Exercise | 229,357 | $0.00 | — |
| Oct 16 | Hoge Stephen | Exercise | 1,675,710 | $12.21 | $20.46M |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $288.24 | -2.24% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $460.28 | -3.80% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $167.57 | -3.96% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $542.50 | -1.19% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $902.90 | -2.98% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.66 | -2.74% | 28.8 | 23.28B |